ConductScience.org, home

Paper25112

Beta-blockers and plasma triglycerides.

Shaw J and 2 others. Br Med J, 1978. Cited by 127 papers, by iCite.

Cite this record

ConductScience Library. Beta-blockers and plasma triglycerides. Papers, record 25112. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25112

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Beta-blockers and plasma triglycerides.
PubMed
Journal
Br Med J
PubMed
Year
1978
PubMed
Publication types
Clinical Trial, Comparative Study, Letter, Randomized Controlled Trial
PubMed
Citations, by iCite
127
iCite
Relative citation ratio, by iCite
7.4
iCite
Revised in PubMed
2019-05-01
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Shaw JJ
2England JDJ D
3Hua ASA S

Source PubMed

Download CSV of authors

Topics4

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Adrenergic beta-AntagonistsMajor topic
TriglyceridesMajor topic
Humans
Hypertension

References2

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
117448Beta-blockers and lipid metabolism.Br Med J1977https://conductscience.org/library/papers/17448PubMed
26244Metabolic effects of beta-adrenoreceptor blockers.Drugs1976https://conductscience.org/library/papers/6244PubMed

Download CSV of references

Cited by25

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 127 citations.

PMIDTitleJournalYearIn PapersSource
7903148Adverse reactions with beta-adrenoceptor blocking drugs. An update.Drug Saf1993https://conductscience.org/library/papers/7903148PubMed
7286043Serum lipoprotein changes during atenolol treatment of essential hypertension.Eur J Clin Pharmacol1981https://conductscience.org/library/papers/7286043PubMed
7104159Effect of pindolol on serum lipids and lipid metabolizing enzymes.Br J Clin Pharmacol1982https://conductscience.org/library/papers/7104159PubMed
7093112The short term effects of propranolol, atenolol and labetalol on antipyrine kinetics in normal subjects.Br J Clin Pharmacol1982https://conductscience.org/library/papers/7093112PubMed
7037030Oxprenolol, methyldopa and lipids in diabetes mellitus.Br J Clin Pharmacol1982https://conductscience.org/library/papers/7037030PubMed
6992822Atenolol v placebo in mild hypertension: renal metabolic and stress antipressor effects.Br J Clin Pharmacol1980https://conductscience.org/library/papers/6992822PubMed
6886585Serum lipids and glucose concentrations in subjects using antihypertensive drugs: Finnmark 1977.J Epidemiol Community Health1983https://conductscience.org/library/papers/6886585PubMed
6732988Effects of short term beta adrenoreceptor blockade on serum lipids and lipoproteins in patients with hypertension or coronary artery disease.Br Heart J1984https://conductscience.org/library/papers/6732988PubMed
6143851[Antihypertensive therapy and lipid metabolism].Klin Wochenschr1984https://conductscience.org/library/papers/6143851PubMed
6143567The effect of two beta-adrenoceptor blockers (mepindolol and atenolol) on blood lipids and platelet aggregation in normal volunteers and essential hypertensive patients.Br J Clin Pharmacol1984https://conductscience.org/library/papers/6143567PubMed
6127218Effects of a new long-acting beta-blocker bopindolol (LT 31-200) on blood pressure, plasma catecholamines, renin and cholesterol in patients with arterial hypertension.Eur J Clin Pharmacol1982https://conductscience.org/library/papers/6127218PubMed
6124416Diuretics of beta-blockers first for hypertension?Drugs1982https://conductscience.org/library/papers/6124416PubMed
6122737What should we do about mild hypertension?J R Coll Physicians Lond1982https://conductscience.org/library/papers/6122737PubMed
6122483Adrenergic mechanisms in control of plasma lipid concentrations.Br Med J (Clin Res Ed)1982https://conductscience.org/library/papers/6122483PubMed
6109778Are selective beta-adrenoceptor blocking drugs an advantage?J R Coll Physicians Lond1981https://conductscience.org/library/papers/6109778PubMed
3709628Lipoprotein lipids and apoproteins during beta-blocker administration: comparison of penbutolol and atenolol.Eur J Clin Pharmacol1986https://conductscience.org/library/papers/3709628PubMed
3154682Comparison of the metabolic effects of long-term treatment with pindolol or atenolol by hypertensive patients.Cardiovasc Drugs Ther1988https://conductscience.org/library/papers/3154682PubMed
2939871Double-blind comparison of the effects of long-term treatment with doxazosin or atenolol on serum lipoproteins.Br J Clin Pharmacol1986https://conductscience.org/library/papers/2939871PubMed
2894885Beta blockers, lipids, and coronary atherosclerosis: fact or fiction?Br Med J (Clin Res Ed)1988https://conductscience.org/library/papers/2894885PubMed
2877846The effects of antihypertensive drugs on serum lipids and lipoproteins. II. Non-diuretic drugs.Drugs1986https://conductscience.org/library/papers/2877846PubMed

See all 25 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/25112

GET https://conductscience.org/api/papers/v1/25112/cited_by?page=2